Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Susan A. Rudders"'
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 8:1186-1195
Epinephrine is life-saving and the only first-line medication in the management of anaphylaxis. At therapeutic doses, it acts rapidly to reverse nearly all symptoms of anaphylaxis, and stabilize mast cells. The standard approved doses administered in
Autor:
Carlos A. Camargo, Ruth J. Geller, Elizabeth Yakaboski, Anna Chen Arroyo, Susan A. Rudders, Lacey B. Robinson, Ashley F. Sullivan, Janice A. Espinola
Publikováno v:
Nutrients, Vol 13, Iss 2318, p 2318 (2021)
Nutrients
Volume 13
Issue 7
Nutrients
Volume 13
Issue 7
There is increasing evidence that early introduction of allergenic foods may decrease the risk of developing IgE-mediated food allergy. Patterns of food introduction before the 2015 publication of the Learning Early about Peanut Allergy (LEAP) trial
Publikováno v:
Current Allergy and Asthma Reports. 21
Anaphylaxis is a severe, life-threatening, systemic allergic reaction that should be recognized and treated promptly. Intramuscular (IM) epinephrine is the first-line treatment for anaphylaxis and there are no absolute contraindications to its use. D
Autor:
Lynda C. Schneider, Amal Assa'ad, Shiv Viswanathan, Kenneth A. Michelson, Marcus Shaker, Kimberly A. Risma, Susan A. Rudders, Ronna L. Campbell, Hugh A. Sampson, Rakesh D. Mistry, Daniel J. Schumacher, David Vyles, John K. Witry, Juhee Lee, Julie Wang, David C. Brousseau, Mark I. Neuman, Timothy E. Dribin, Carlos A. Camargo, David Schnadower, Jonathan M. Spergel, Mariana Castells, Lisa M. Vaughn, Erica M. Page
Publikováno v:
J Allergy Clin Immunol
Background The use of inconsistent definitions for anaphylaxis outcomes limits our understanding of the natural history and epidemiology of anaphylaxis, hindering clinical practice and research efforts. Objective Our aim was to develop consensus defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2833710d3a101477a1703d335826cf5a
https://europepmc.org/articles/PMC8006564/
https://europepmc.org/articles/PMC8006564/
Autor:
Mohammad Kamal Faridi, Lacey B. Robinson, Carlos A. Camargo, Anna Chen Arroyo, Susan A. Rudders
Publikováno v:
J Allergy Clin Immunol Pract
BACKGROUND: Anaphylaxis is a potentially life-threatening allergic reaction. The overall prevalence of anaphylaxis appears to be rising in children, but temporal trends among infants and toddlers are not well studied. OBJECTIVE: To characterize the t
Autor:
Lacey B. Robinson, Mohammad Kamal Faridi, Carlos A. Camargo, Anna Chen Arroyo, Susan A. Rudders
Publikováno v:
Annals of Allergy, Asthma & Immunology. 126:168-174.e3
Background Anaphylaxis is a potentially fatal acute allergic reaction. Its overall prevalence appears to be rising, but little is known about US hospitalization trends among infants and toddlers. Objective To identify the trends and predictors of hos
Autor:
Susan A. Rudders, Ruth J. Geller, Kohei Hasegawa, Cindy S. Bauer, Jonathan M. Spergel, Ashley F. Sullivan, Lacey B. Robinson, Carlos A. Camargo, Anna Chen Arroyo
Publikováno v:
Journal of Allergy and Clinical Immunology. 147:AB45
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 3:57-62
Food-induced anaphylaxis (FIA) is potentially life threatening. Prompt administration of epinephrine is universally recommended by current treatment guidelines.To identify factors associated with early epinephrine treatment for FIA and to specificall
Publikováno v:
Journal of Allergy and Clinical Immunology. 134:1125-1130
Background Although reported risk factors for severe anaphylaxis include older age, presence of comorbid medical conditions, and concomitant medications, previous studies have used varying definitions for anaphylaxis and heterogeneous methodology. Ob
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 2:46-51
Background Drugs are a common cause of anaphylaxis, which is potentially life threatening. Objective We sought to describe US patients with an emergency department (ED) visit or hospitalization for drug-induced anaphylaxis (DIA), including postdischa